Explore evidence

68.1 %Awareness of cervical cancer screening was 68.1% among women of a Catholic Parish in Nsukka Local Government Area of Enugu State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

Cervical cancer is the second leading cause of cancer morbidity and mortality in Nigeria.

Nigeriacancer du col de l'utéruspublished 2022Cancer reports (Hoboken, N.J.)PubMeddocument of 4 observations

0.953 odds_ratioIncreasing age was an independent predictor of lower brachytherapy utilization (p = 0.005, OR = 0.953, 95% CI = 0.921–0.986).

Nigeriacancer du col de l'utérusobserved March 2021 to June 2024PubMeddocument of 6 observations

Cervical cancer is the second highest cancer among women in Nigeria.

Nigeriacancer du col de l'utéruspublished 2019Nigerian journal of clinical practicePubMeddocument of 7 observations

Cervical cancer remains a significant public health issue in low- and middle-income countries, especially in Western sub-Saharan Africa and Nigeria.

Nigeriacancer du col de l'utéruspublished 2025International journal of cancerPubMeddocument of 3 observations

3 per_10In a rural community in Enugu State, Nigeria, only 3 out of every 10 women were aware of cervical cancer and its preventive measures.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 8 observations

0.6 %Only two respondents (0.6%) had undergone cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations

173 patientsAmong 343 cervical cancer patients, 173 (50.43%) received brachytherapy.

Nigeriacancer du col de l'utérusobserved March 2021 to June 2024PubMeddocument of 6 observations

45.2 %Only 45.2% of women in Taraba, North-East Nigeria regularly engaged in cervical cancer screening and other prevention practices.

Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

87.4 %87.4% of the respondents had not accompanied their wife/female partner for cervical cancer screening.

Nigeriacancer du col de l'utérusobserved 2018published 2023PloS onePubMeddocument of 14 observations

28.8 %Cervical cancer awareness was low at 28.8% among women aged 25 to 65 years in Makurdi, North-Central Nigeria.

Nigeriacancer du col de l'utéruspublished 2025Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

13.4 yearsAmong HIV-positive women, PhenoAge acceleration (PhenoAA) was on average 13.4 years higher in women with invasive cervical cancer compared to cancer-free women.

Nigeriacancer du col de l'utérus · VIH/sidapublished 2022Frontiers in public healthPubMeddocument of 4 observations

88.93 GyThe mean dose to D90 of the HR-CTV was 88.93 ± 4.20 Gy in Group B patients.

Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations

60.8 %The primary case finder screening sensitivity was 60.8% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

4.5 %4.5% of respondents were aware that HPV infection is a causative factor for cervical cancer in a community health outreach program in Ituku, Enugu State, Nigeria.

Nigeriacancer du col de l'utérus · infection à HPVobserved 2024published 2026Rural and remote healthPubMeddocument of 8 observations

41.9 %Less than half (41.9%) of the female secondary school teachers in Enugu metropolis had good knowledge of the cervical cancer vaccine.

Nigeriacancer du col de l'utérusobserved 2017published 2021The Pan African medical journalPubMeddocument of 7 observations

27.3 %Cervical cancer accounted for 66 cases (27.3%) among 242 gynecological cancer cases at Federal University Teaching Hospital, Owerri, from January 2020 to November 2022.

Nigeriacancer du col de l'utérusobserved January 2020 to November 2022published 2023The Pan African medical journalPubMeddocument of 8 observations

66.5 %Post-intervention, knowledge of cervical cancer symptoms increased to 66.5% in the intervention group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

41.7 %41.7% of rural women in North Central Nigeria had fair/good consolidated knowledge of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations

71.5 %The primary case finder screening specificity was 71.5% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

69.7 %69.7% of the women cited lack of knowledge of where to go for cervical cancer screening as a reason for not being screened.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

88 %88.0% of women in Taraba, North-East Nigeria had appropriate knowledge about the risk factors of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

2,800 women2,800 women had more than one cervical cancer screening visit between 2006 and 2016 at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utérusobserved 2006–2016published 2024Cancer causes & control : CCCPubMeddocument of 5 observations

32.4 %32.4% of the respondents were cervical cancer patients.

Nigeriacancer du col de l'utéruspublished 2026BMC women's healthPubMeddocument of 6 observations

26 %Comorbidity affects about 26% of cervical cancer patients in Nigeria.

Nigeriacancer du col de l'utéruspublished 2025International healthPubMeddocument of 2 observations